Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery.

Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery.

Item
http://www.wikidata.org/entity/Q33598869
Prognosis Research Strategy (PROGRESS) 3: prognostic model researchEvaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery diseasePersonalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.From accuracy to patient outcome and cost-effectiveness evaluations of diagnostic tests and biomarkers: an exemplary modelling study.Use of the self-controlled case series method in drug safety assessmentCost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension.Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients.Assessing the incremental value of diagnostic and prognostic markers: a review and illustration.Assessing the value of cardiac biomarkers: going beyond diagnostic accuracy?Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis.Zinc protoporphyrin levels have added value in the prediction of low hemoglobin deferral in whole blood donors.What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacement.Cohort profile: the Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort.A method for the early health technology assessment of novel biomarker measurement in primary prevention programs
P2860

Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery.

Item
http://www.wikidata.org/entity/Q33598869
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Assessing the cost effectivene ...... g for coronary artery surgery.
@ast
Assessing the cost effectivene ...... g for coronary artery surgery.
@en
type
label
Assessing the cost effectivene ...... g for coronary artery surgery.
@ast
Assessing the cost effectivene ...... g for coronary artery surgery.
@en
prefLabel
Assessing the cost effectivene ...... g for coronary artery surgery.
@ast
Assessing the cost effectivene ...... g for coronary artery surgery.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Assessing the cost effectivene ...... g for coronary artery surgery.
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P921
P932